Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Meningioma × Bevacizumab × Clear all

Phase

Status

Sponsor Class

OTHER 3 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 9 Lung Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Breast Neoplasms 8 Rectal Neoplasms 7 Adenocarcinoma of Lung 6 Colonic Neoplasms 5 Glioblastoma 3 Brain Neoplasms 3 Adenocarcinoma, Bronchiolo-Alveolar 3 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Gliosarcoma 2 Carcinoma 2 Breast Neoplasms, Male 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Oligodendroglioma 1 Non Small Cell Lung Cancer Metastatic 1 Meningioma 1 Medulloblastoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Inflammatory Breast Neoplasms 1 Glioma 1 Fallopian Tube Neoplasms 1 Erythema Multiforme 1 Ependymoma 1 Cognition Disorders 1

Interventions

Radiotherapy 2 Hydroxyurea 2 lutetium Lu 177 dotatate 1 emvododstat 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Proton Therapy 1 Octreotide 1 Observation 1 Mifepristone 1 Ifosfamide 1 Everolimus 1 Chemotherapy, Adjuvant 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡